Showing results (931-940 of 1,120) with videos related to

Sort By:
Pageof 112
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 12, 2023
P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET TrialPatricia O Guimarães, Marcelo Franken, Caio A M Tavares, et al.
Lancet (London, England)|September 8, 2020
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trialRemo H M Furtado, Otavio Berwanger, Henrique A Fonseca, et al.
JAMA|September 3, 2020
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical TrialBruno M Tomazini, Israel S Maia, Alexandre B Cavalcanti, et al.
The New England Journal of Medicine|September 1, 2025
Early Withdrawal of Aspirin after PCI in Acute Coronary SyndromesPatricia O Guimarães, Marcelo Franken, Caio A M Tavares, et al.
JAMA Network Open|May 25, 2023
Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical TrialJeffrey S Berger, Matthew D Neal, Lucy Z Kornblith, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|August 1, 2024
Inflammatory Profile of Chronic Rhinosinusitis With Nasal Polyp Patients in Brazil: Multicenter StudyFabrizio R Romano, Fabiana C P Valera, Marco A Fornazieri, et al.
The New England Journal of Medicine|November 16, 2020
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral ValveHelio P Guimarães, Renato D Lopes, Pedro G M de Barros E Silva, et al.
Scientific Reports|February 20, 2024
Primary results of the brazilian registry of atherothrombotic disease (NEAT)Pedro G M de Barros E Silva, Charlene Troiani do Nascimento, Rodrigo Pinto Pedrosa, et al.
BMJ (Clinical Research Ed.)|January 21, 2021
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trialViviane C Veiga, João A G G Prats, Danielle L C Farias, et al.
The New England Journal of Medicine|July 25, 2020
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19Alexandre B Cavalcanti, Fernando G Zampieri, Regis G Rosa, et al.
Pageof 112